INDV Indivior Plc

  1. Stocks
  2. Healthcare
  3. NASDAQ: INDV

Price (delayed)

$40.525

Market cap

$4.94B

P/E Ratio

20.16

Dividend/share

N/A

EPS

$2.01

Enterprise value

$5.27B

?
Relative Growth: Rel. Growth: 76
Relative Strength: Rel. Strength: 91
Relative Valuation: Rel. Valuation: 80
Relative Profitability: Rel. Profitability: 85

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline ...

Highlights
The EPS has grown by 20% from the previous quarter
The net income has increased by 20% since the previous quarter
The equity has grown by 49% YoY but it has contracted by 47% from the previous quarter
The quick ratio has grown by 18% from the previous quarter but it has contracted by 4.9% YoY
Indivior's debt has increased by 45% from the previous quarter and by 38% YoY
INDV's price to earnings (P/E) is 4.5% higher than its last 4 quarters average of 19.3
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://www.indivior.com
Peers: PRGO TEVA AMRX

Key stats

What are the main financial stats of INDV

INDV stock price

How has the Indivior stock price performed over time
Intraday
0.04%
1 week
-0.04%
1 month
-2.28%
1 year
141.08%
YTD
12.95%
QTD
-1.23%

Financial performance

How have Indivior's revenue and profit performed over time
Revenue
$1.29B
Gross profit
$1.05B
Operating income
$333M
Net income
$251M
Gross margin
81.3%
Net margin
19.4%
The operating income is up by 27% since the previous quarter
INDV's operating margin is up by 22% since the previous quarter
The net income has increased by 20% since the previous quarter
Indivior's net margin has increased by 15% from the previous quarter

Price vs fundamentals

How does INDV's price correlate with its fundamentals

Growth

What is Indivior's growth rate over time

Valuation

What is Indivior stock price valuation
INDV P/E details
P/E
20.16
P/B
N/A
P/S
3.89
EV/EBIT
15.75
EV/EBITDA
14.9
EV/Sales
4.09
The EPS has grown by 20% from the previous quarter
INDV's price to earnings (P/E) is 4.5% higher than its last 4 quarters average of 19.3
The equity has grown by 49% YoY but it has contracted by 47% from the previous quarter
The stock's price to sales (P/S) is 44% more than its last 4 quarters average of 2.7
INDV's revenue is up by 10% year-on-year and by 4.2% since the previous quarter

Efficiency

How efficient is Indivior business performance
Indivior's ROA has increased by 24% from the previous quarter
The ROS has grown by 13% from the previous quarter
Indivior's return on invested capital has decreased by 8% QoQ

Dividends

What is INDV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INDV.

Financial health

How did Indivior financials performed over time
Indivior's total assets is 11% lower than its total liabilities
The current ratio has grown by 21% from the previous quarter but it has contracted by 2.3% YoY
INDV's total liabilities is down by 19% year-on-year but it is up by 3.2% since the previous quarter
The debt to equity has dropped by 172% year-on-year
The equity has grown by 49% YoY but it has contracted by 47% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.